🔎 Trials Near Me

Utama › Kanser (semua jenis) › Nebraska › Omaha

Kajian klinikal Kanser (semua jenis) di Omaha, NE

18 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Omaha (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Mengambil pesertaFasa 2/3
  • Nebraska Medicine, Omaha
  • Nebraska Medicine - Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06989437

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Mengambil pesertaFasa 3
  • University of Nebraska Medical Center, Omaha
  • Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06901531

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Mengambil pesertaFasa 2
  • University of Nebraska Medical Center, Omaha
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Mengambil pesertaFasa 2/3
  • University Of Nebraska Medical Center, Omaha
Semua umur · Semua jantina · Dikemas kini 18 Sep 2026 · NCT03435796

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Mengambil pesertaFasa 2
  • University of Nebraska Medical Center, Omaha
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Mengambil pesertaFasa 3
  • Nebraska Cancer Specialists, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06072612

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

Mengambil pesertaFasa 1
  • Nebraska Cancer Specialists, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07660055

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Children's Hospital and Medical Center of Omaha, Omaha
  • University of Nebraska Medical Center, Omaha
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Mengambil pesertaFasa 3
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Nebraska Medicine-Village Pointe, Omaha
  • dan 8 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06580314

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Mengambil pesertaFasa 1/2
  • Nebraska Cancer Specialists, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT04198766

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Mengambil pesertaFasa 1
  • Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05650632

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Mengambil peserta
  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Jun 2026 · NCT05486572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Mengambil pesertaFasa 1/2
  • Fred and Pamela Buffett Cancer Center, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT03328078

GEMINI-NSCLC: NSCLC Biomarker Study

Mengambil pesertaKajian pemerhatian
  • Nebraska Cancer Specialists, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Feb 2026 · NCT05236114

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Omaha
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Nebraska Medical Center, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2025 · NCT05970497

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Mengambil pesertaKajian pemerhatian
  • Nebraska Cancer Specialists, Omaha
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2025 · NCT05234177

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Mengambil peserta
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medicine, Omaha
  • Nebraska Medicine - Bellevue, Bellevue · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Nov 2024 · NCT03860883

Kajian Kanser (semua jenis) di bandar lain

Kajian lain di Omaha

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.